• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患者肺部和胃肠道中CFTR的定位与发育作用

Mapping and Development Role of CFTR in Lung and Gastrointestinal Tract of Cystic Fibrosis Patients.

作者信息

Li Danni, Han XiaoXuan, Habgood Mark, Schneider-Futschik Elena K

机构信息

Department of Biochemistry and Pharmacology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC 3010, Australia.

出版信息

ACS Pharmacol Transl Sci. 2023 Feb 13;6(3):355-360. doi: 10.1021/acsptsci.2c00233. eCollection 2023 Mar 10.

DOI:10.1021/acsptsci.2c00233
PMID:36926454
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10012249/
Abstract

In cystic fibrosis (CF) the ability of the CF transmembrane conductance regulator (CFTR) protein to mediate chloride and water transport is disrupted. While much progress has been made in CF research leading to effective treatments to improve CFTR function, including small molecule modulators, patients present with varying disease manifestations and responses to therapy. For many CF-affected organs, disease onset is known to occur during development before treatments can be administered and progresses over time leading to irreversible damage to these organs. Thus, the role of functional CFTR protein, in particular, during early development needs to be further elucidated. Studies have detected CFTR proteins at very early gestational stages and revealed temporally and spatially variable CFTR expression patterns in fetuses, suggesting a potential role of CFTR in fetal development. However, the actual mechanisms of how defective CFTR in CF results in fetal morphogenetic abnormalities are yet to be established. This review aims to summarize fetal CFTR expression patterns specifically in the lung, pancreas, and gastrointestinal tract (GIT), as compared to adult patterns. Case studies of structural abnormalities in CF fetuses and newborns and the role of CFTR in fetal development will also be discussed.

摘要

在囊性纤维化(CF)中,CF跨膜传导调节因子(CFTR)蛋白介导氯离子和水运输的能力受到破坏。虽然CF研究已取得很大进展,开发出了包括小分子调节剂在内的有效治疗方法来改善CFTR功能,但患者的疾病表现和对治疗的反应各不相同。对于许多受CF影响的器官,已知疾病在能够进行治疗之前的发育过程中就已开始,并随时间推移而进展,导致这些器官发生不可逆损伤。因此,功能性CFTR蛋白的作用,尤其是在早期发育过程中的作用,需要进一步阐明。研究已在妊娠早期阶段检测到CFTR蛋白,并揭示了胎儿中CFTR表达模式在时间和空间上的变化,这表明CFTR在胎儿发育中可能发挥作用。然而,CF中缺陷性CFTR导致胎儿形态发生异常的实际机制尚未明确。本综述旨在总结与成人模式相比,胎儿CFTR在肺、胰腺和胃肠道(GIT)中的特异性表达模式。还将讨论CF胎儿和新生儿结构异常的案例研究以及CFTR在胎儿发育中的作用。

相似文献

1
Mapping and Development Role of CFTR in Lung and Gastrointestinal Tract of Cystic Fibrosis Patients.囊性纤维化患者肺部和胃肠道中CFTR的定位与发育作用
ACS Pharmacol Transl Sci. 2023 Feb 13;6(3):355-360. doi: 10.1021/acsptsci.2c00233. eCollection 2023 Mar 10.
2
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].[中国专家共识声明:囊性纤维化的诊断与治疗(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971.
3
A Developmental Role of the Cystic Fibrosis Transmembrane Conductance Regulator in Cystic Fibrosis Lung Disease Pathogenesis.囊性纤维化跨膜传导调节因子在囊性纤维化肺病发病机制中的发育作用
Front Cell Dev Biol. 2021 Oct 11;9:742891. doi: 10.3389/fcell.2021.742891. eCollection 2021.
4
Correction of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis mice.瓦地那非纠正囊性纤维化小鼠胃肠道中氯离子转运和 CFTR 蛋白定位错误。
PLoS One. 2013 Oct 24;8(10):e77314. doi: 10.1371/journal.pone.0077314. eCollection 2013.
5
A foetus with cystic fibrosis - To treat or not to treat?囊性纤维化胎儿——治还是不治?
Respir Med Res. 2023 Jun;83:101006. doi: 10.1016/j.resmer.2023.101006. Epub 2023 Mar 5.
6
Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.囊性纤维化个体化医学:从调节剂开发到治疗罕见 CFTR 突变的囊性纤维化患者。
Am J Physiol Lung Cell Mol Physiol. 2018 Apr 1;314(4):L529-L543. doi: 10.1152/ajplung.00465.2017. Epub 2017 Dec 14.
7
Triplet CFTR modulators: future prospects for treatment of cystic fibrosis.三联体CFTR调节剂:治疗囊性纤维化的未来前景。
Ther Clin Risk Manag. 2018 Dec 6;14:2375-2383. doi: 10.2147/TCRM.S147164. eCollection 2018.
8
Emerging Cystic Fibrosis Transmembrane Conductance Regulator Modulators as New Drugs for Cystic Fibrosis: A Portrait of Pharmacology and Clinical Translation.新型囊性纤维化跨膜传导调节因子调节剂作为囊性纤维化的新药:药理学与临床转化概述
ACS Pharmacol Transl Sci. 2019 Oct 2;3(1):4-10. doi: 10.1021/acsptsci.9b00060. eCollection 2020 Feb 14.
9
Small-molecule drugs for cystic fibrosis: Where are we now?用于治疗囊性纤维化的小分子药物:我们目前处于什么阶段?
Pulm Pharmacol Ther. 2022 Feb;72:102098. doi: 10.1016/j.pupt.2021.102098. Epub 2021 Nov 15.
10
Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis.通过 SLC6A14 依赖性氨基酸摄取增强人支气管上皮细胞中的囊性纤维化跨膜电导调节剂功能。对囊性纤维化治疗的启示。
Am J Respir Cell Mol Biol. 2019 Dec;61(6):755-764. doi: 10.1165/rcmb.2019-0094OC.

引用本文的文献

1
Recommended Tool Compounds for Modifying the Cystic Fibrosis Transmembrane Conductance Regulator Channel Variants.用于修饰囊性纤维化跨膜传导调节因子通道变体的推荐工具化合物。
ACS Pharmacol Transl Sci. 2024 Mar 14;7(4):933-950. doi: 10.1021/acsptsci.3c00362. eCollection 2024 Apr 12.
2
Ocular development after highly effective modulator treatment early in life.生命早期接受高效调节剂治疗后的眼部发育
Front Pharmacol. 2023 Sep 19;14:1265138. doi: 10.3389/fphar.2023.1265138. eCollection 2023.

本文引用的文献

1
CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system.使用哺乳动物膜双杂交高通量筛选系统进行 CFTR 相互作用组图谱绘制。
Mol Syst Biol. 2022 Feb;18(2):e10629. doi: 10.15252/msb.202110629.
2
Cystic Fibrosis: Systems Biology Analysis from Homozygous p.Phe508del Variant Patients' Samples Reveals Perturbations in Tissue-Specific Pathways.囊性纤维化:来自纯合 p.Phe508del 变异患者样本的系统生物学分析揭示了组织特异性途径的紊乱。
Biomed Res Int. 2021 Dec 2;2021:5262000. doi: 10.1155/2021/5262000. eCollection 2021.
3
Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis.囊性纤维化跨膜电导调节因子药物对囊性纤维化肺部炎症的抗炎作用。
Int J Mol Sci. 2021 Jul 16;22(14):7606. doi: 10.3390/ijms22147606.
4
Entry of cystic fibrosis transmembrane conductance potentiator ivacaftor into the developing brain and lung.囊性纤维化跨膜传导调节剂依伐卡托进入发育中的脑和肺。
J Cyst Fibros. 2021 Sep;20(5):857-864. doi: 10.1016/j.jcf.2021.06.005. Epub 2021 Jun 27.
5
The Balance between the Safety of Mother, Fetus, and Newborn Undergoing Cystic Fibrosis Transmembrane Conductance Regulator Treatments during Pregnancy.孕期接受囊性纤维化跨膜传导调节因子治疗的母亲、胎儿和新生儿的安全平衡。
ACS Pharmacol Transl Sci. 2020 Aug 19;3(5):835-843. doi: 10.1021/acsptsci.0c00098. eCollection 2020 Oct 9.
6
What Role Does CFTR Play in Development, Differentiation, Regeneration and Cancer?囊性纤维化跨膜传导调节因子(CFTR)在发育、分化、再生和癌症中扮演什么角色?
Int J Mol Sci. 2020 Apr 29;21(9):3133. doi: 10.3390/ijms21093133.
7
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine.CFTR调节剂:精准医学时代囊性纤维化的新面貌
Front Pharmacol. 2020 Feb 21;10:1662. doi: 10.3389/fphar.2019.01662. eCollection 2019.
8
Re-imagining cystic fibrosis care: next generation thinking.重新构想囊性纤维化护理:下一代思维。
Eur Respir J. 2020 May 27;55(5). doi: 10.1183/13993003.02443-2019. Print 2020 May.
9
Cystic Fibrosis Lung Disease: An Overview.囊性纤维化肺病:概述。
Respir Care. 2020 Feb;65(2):233-251. doi: 10.4187/respcare.06697. Epub 2019 Nov 26.
10
Cystic Fibrosis: Pathophysiology of Lung Disease.囊性纤维化:肺部疾病的病理生理学。
Semin Respir Crit Care Med. 2019 Dec;40(6):715-726. doi: 10.1055/s-0039-1694021. Epub 2019 Oct 28.